• Sleep Apnea Linked to High Blood Pressure in Lungs of Adults With Scleroderma
  • ACR CRISS Score a Reliable Measure of Therapy Effectiveness in dcSSc Patients, Corbus Says
  • National Survey Seeks to Assess Full Social, Economic Burdens of Rare Diseases in US
  • Orencia Shows Promise in Treating Localized Scleroderma in Children, Adults
  • CellCept, Cyclophosphamide Both Improve Patient-reported Outcomes in SSc-ILD, Phase 2 Data Show
  • Alexion Charitable Foundation Giving $1.1M to Assist Rare Disease Community During Pandemic
  • Rheumatology Expert to Lead Scleroderma Program at Cedars-Sinai’s Kao Institute
  • Shear-wave Elastography May Best Capture Changes in Skin Stiffness
  • Coalition Will Address Racial Disparities in Rare Disease Communities
  • Virtual Walks, Other Activities to Spotlight Scleroderma Awareness Month
  • TLY012 Receives FDA Orphan Drug Status for Systemic Scleroderma
  • COVID-19 Delaying Rare Disease and Gene Therapy Trials, Pharma Execs Say